Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
InChi: InChI=1S/C27H21N5/c1-3-9-21(10-4-1)22-16-14-20(15-17-22)19-29-27-25(23-11-5-2-6-12-23)31-32-26(30-27)24-13-7-8-18-28-24/h1-18H
Continuous Noninvasive Arterial Pressure Monitoring Using the Vascular Unloading Technique (CNAP System) in Obese Patients During Laparoscopic Bariatric Operations
The neuropeptide substance P (SP) that are mediated by the neurokinin 1 receptor (NK1-R) desensitize and resensitize
VSMCs) treatment inhibits PDGF-stimulated vascular smooth muscle cell proliferation in a dose dependent fashion with an IC50 of 0
especially at the late stage of treatment for AIDS patients developing multi-drug-resistant strains
AR-A014418 - CAS# 487021-52-3 TAC Sirt2 Degrader-1 InChi: InChI=1S/C27H21N5/c1-3-9-21(10-4-1)22-16-14-20(15-17-22)19-29-27-25(23-11-5-2-6-12-23)31-32-26(30-27)24-13-7-8-18-28-24/h1-18HAR A014418 , also known as SN 4521, is a labeled Glycogen Synthase Kinase 3 (GSK 3) inhibitor. AR A014418 suppresses pancreatic cancer cell growth via inhibition of GSK 3 mediated Notch1 expression. AR A014418 decreases neuropathic pain in mice: evidence for the mechanisms of action. AR A014418 and B6B3O prevent human immunodeficiency virus mediated neurotoxicity in primary human neurons. Product information CAS Number: 487021 52 3 Molecular Weight: